IDH1 Mutant Glioma Favors Group 3 Innate Lymphoid Cells and Is Resistant to Immune Checkpoint Expression.
IDH1突变型胶质瘤偏好第3组固有淋巴细胞,并且对免疫检查点表达具有抵抗力。
期刊:Inflammation Research
影响因子:5.4
doi:10.1007/s00011-026-02223-8
Erdem Serife, Haliloglu Yesim, Uslu Inayet Nur, Houran Mohammad, Ulutabanca Halil, Vural Alperen, Erturhan Mehmet Berat, Canatan Halit, Eken Ahmet